Rehabilitation Enhanced by Partial Arterial Inflow Restrictions
NCT ID: NCT02746458
Last Updated: 2024-05-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
250 participants
INTERVENTIONAL
2016-04-01
2024-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Role of Blood Flow Restriction Therapy in Postoperative Elderly Patients With Hip Fracture
NCT04809714
BFR DISTRAD NON OP: Blood Flow Restricted Training During Rehabilitation Following Distal Radius Fracture
NCT03056950
RFN-Advanced Retrograde Femoral Nailing System
NCT05668117
Early Weight Bearing on Supracondylar Distal Femur Fractures in Elderly Patients
NCT02475941
Comminuted Intra-Articular Distal Tibia Fracture Fixation Using Computer Techniques
NCT02845245
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard of Care Physical Therapy
This group will receive the standard of care physical therapy program for 6 weeks.
No interventions assigned to this group
Blood Flow Restriction Plus Standard of Care Physical Therapy
This group will receive the same standard of care physical therapy program for 6 weeks plus blood flow restriction.
Blood Flow Restriction
Brief and intermittent blood flow restriction via a Delfi PTSII Tourniquet System will be used during physical therapy.
Delfi PTSII Tourniquet System
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blood Flow Restriction
Brief and intermittent blood flow restriction via a Delfi PTSII Tourniquet System will be used during physical therapy.
Delfi PTSII Tourniquet System
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Admitted to one of the participating clinical centers for operative treatment of a closed diaphyseal femur fracture with one of the following OTA codes: 32A, 32B or 32C (treated with an IM Nail).
Exclusion Criteria
2. Additional fracture, dislocations or soft tissue injuries to the study limb that would compromise the ability to weight bear as tolerated and initiate PT within 28 days of definitive fixation.
3. Any fractures, dislocations or soft tissue injuries to the contralateral limb or pelvis that would compromise the ability to weight bear as tolerated and initiate PT within 28 days of definitive fixation.
4. Any treatment of the study injury in either group that would preclude application of the tourniquet cuff (e.g. vascular reconstruction, wound, flap, or skin graft).
5. Injuries to other body systems (or other medical conditions) that would preclude the ability to weight bear as tolerated and initiate PT within 28 days of definitive fixation (e.g. spinal cord deficit; severe traumatic brain injury).
6. Use of blood flow restriction (BFR) at any time between treatment and the start of physical therapy for the study.
7. Non-ambulatory pre-injury.
8. Morbidly obese (BMI \> 40).
9. History of Peripheral Artery Disease and/or Peripheral Vascular Disease (PAD/PVD).
10. Current or history of venous thromboembolism.
11. Impaired circulation or peripheral vascular compromise.
12. Previous revascularization at the study injury site.
13. Extremities with dialysis access.
14. Current diagnosis of acidosis.
15. Diagnosis of sickle cell anemia.
16. Current infection of the study injury.
17. Current tumor (malignant or benign) distal to study injury and future tourniquet placement.
18. Current use of medications or supplements that are known to increase clotting risk.
19. Diagnosis of severe hypertension (blood pressure of 180/110).
20. Skin grafts in which all bleeding points must be readily distinguished.
21. Secondary or delayed surgical procedures to study injury after immobilization.
22. Vascular grafting to the study injury.
23. History of lymphotomies.
24. Current diagnosis of cancer.
25. Unable to speak either English or Spanish.
26. Severe problems with maintaining follow-up (e.g. patients who are prisoners, homeless at the time of injury, who are intellectually challenged without adequate family support, or have document psychiatric disorders).
27. Unable to provide informed consent.
28. Patient has not been cleared to start physical therapy at the time of consent.
29. Patient is pregnant.
30. Patient received BFR between date of injury and start of Physical Therapy.
18 Years
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Major Extremity Trauma Research Consortium
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lisa Reider, PhD
Role: STUDY_DIRECTOR
Major Extremity Trauma Research Consortium Coordinating Center
Daniel J Stinner, MD
Role: PRINCIPAL_INVESTIGATOR
San Antonio Military Medical Center
Ellen J MacKenzie, PhD
Role: PRINCIPAL_INVESTIGATOR
Major Extremity Trauma Research Consortium Coordinating Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Methodist Hospital
Indianapolis, Indiana, United States
University of Maryland Medical Center
Baltimore, Maryland, United States
Walter Reed National Military Medical Center
Bethesda, Maryland, United States
Barnes Jewish Hospital
St Louis, Missouri, United States
Carolinas Medical Center
Charlotte, North Carolina, United States
MetroHealth
Cleveland, Ohio, United States
University of Texas Health Science Center at Houston
Houston, Texas, United States
San Antonio Military Medical Center
San Antonio, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
W81XWH-15-2-0067
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.